Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New insights into progressive supranuclear palsy.

D S Albers1, S J Augood

  • 1Dept of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USA. daa2010@mail.med.cornell.edu

Trends in Neurosciences
|May 18, 2001
PubMed
Summary

Oxidative damage and mitochondrial dysfunction contribute to neurodegenerative diseases like progressive supranuclear palsy (PSP). This review explores genetic and biochemical evidence highlighting their roles in PSP pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse.

The European journal of neuroscience·2006
Same author

Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.

Journal of the neurological sciences·2003
Same author

Non-radioactive in situ hybridization using alkaline phosphatase-labelled oligonucleotides.

International review of neurobiology·2002
Same author

Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study.

Neurology·2002
Same author

Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy.

Journal of neuroscience research·2001
Same author

Gene expression profiling in the post-mortem human brain--no cause for dismay.

Journal of chemical neuroanatomy·2001

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Neurodegenerative diseases share common pathogenic mechanisms.
  • Oxidative damage and mitochondrial dysfunction are implicated in Parkinson's and Alzheimer's diseases.
  • Progressive supranuclear palsy (PSP) is a rare parkinsonian disorder characterized by tau pathology.

Purpose of the Study:

  • To review the roles of oxidative damage and mitochondrial dysfunction in the pathogenesis of progressive supranuclear palsy (PSP).
  • To highlight recent genetic and biochemical findings offering new insights into PSP.

Main Methods:

  • Literature review of genetic and biochemical data related to PSP.
  • Focus on studies investigating oxidative stress and mitochondrial function in PSP.

Related Experiment Videos

Main Results:

  • Evidence suggests oxidative damage is a key factor in PSP.
  • Mitochondrial dysfunction is increasingly recognized as contributing to PSP.
  • Genetic and biochemical data provide novel perspectives on PSP etiology.

Conclusions:

  • Oxidative damage and mitochondrial dysfunction are critical contributors to progressive supranuclear palsy (PSP) pathogenesis.
  • Further research into these mechanisms may reveal new therapeutic targets for PSP.